Stay updated on REFINE: Natalizumab Regimens in Relapsing MS Clinical Trial

Sign up to get notified when there's something new on the REFINE: Natalizumab Regimens in Relapsing MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the REFINE: Natalizumab Regimens in Relapsing MS Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number has been updated from **v3.5.2** to **v3.5.3**. This reflects a site or interface release rather than a change to the clinical trial information.
    Difference
    0.0%
    Check dated 2026-04-24T05:57:58.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:34:50.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Padova, Italy is added and Padua, Italy is removed from the Italy study locations.
    Difference
    0.0%
    Check dated 2026-04-09T21:35:44.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Naples, Italy was added to the locations list and Napoli, Italy was removed from the locations list.
    Difference
    0.0%
    Check dated 2026-03-26T11:29:10.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T04:21:03.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-11T20:20:39.000Z thumbnail image

Stay in the know with updates to REFINE: Natalizumab Regimens in Relapsing MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the REFINE: Natalizumab Regimens in Relapsing MS Clinical Trial page.